Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented new translational data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting. The study demonstrates that ...

A new technique enables rapid and accurate cell density measurement at single-cell resolution, providing insights into cell ...

A novel machine learning model enhances colorectal cancer (CRC) prognosis and immunotherapy response prediction by ...

Recent research points to the potential utility of a familiar sounding foe–herpes virus–in the fight against cancer.

The Cocoon® (from Lonza) is a functionally closed, sterile, efficient manufacturing platform, which combined with our ...

Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...

The first patient has received treatment with mavrostobart plus chemo in the phase 1/2 MORNINGSTAR trial for advanced solid ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after ...

KRAS mutations are among the most common genetic alterations in cancer and are considered particularly difficult to treat. In ...

Bcl6 regulates the lineage stability and suppressive function of Treg cells in head and neck squamous cell carcinoma ...

Bioengineering assistant professor Girgis Obaid at the University of Texas at Dallas and cancer researcher Rolf Brekken at UT ...

Macrophages and other immune cells are the natural frontline immune warriors of our body, defending the body against invading ...